← ANALYST RATINGS · TIPRANKS
Anteris Technologies Global Corp. (AVR): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy1 Hold0 Sell
Ratings of 3 analysts in the last 3 months12-month forecast
Based on 3 price targets given in the last 3 months, the average target is $13.67, the highest $16.00, the lowest $10.00. The average is +125.9% from the last price of $6.05.
Analyst ratings 7
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $6.00 → $6.50+8.3% | Hold | +7.4% | Reiterated | 16.10.26on TipRanks 20:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $6.00 → $6.50+8.3% | Hold | +7.4% | Reiterated | 16.10.26on TipRanks 20:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $6.50 → $6.00−7.7% | Hold | −0.8% | Reiterated | 15.10.26on TipRanks 14:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $6.50 → $6.00−7.7% | Hold | −0.8% | Reiterated | 15.10.26on TipRanks 14:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $6.50 → $6.00−7.7% | Hold | −0.8% | Reiterated | 15.10.26on TipRanks 14:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $6.50 → $6.00−7.7% | Hold | −0.8% | Reiterated | 15.10.26on TipRanks 14:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $6.50 → $6.00−7.7% | Sell | −0.8% | Downgrade | 14.10.26on TipRanks 08:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $6.50 → $6.00−7.7% | Hold | −0.8% | Reiterated | 14.10.26on TipRanks 08:05 | — | |
| Unknown Analyst | Cantor Fitzgerald | $15.00 | Buy | +147.9% | Reiterated | 14.10.26on TipRanks 08:05 | −1.9%next day +1.3% | ↗ |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $6.00 → $6.50+8.3% | Sell | +7.4% | Downgrade | 11.10.26on TipRanks 17:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $6.50 → $6.00−7.7% | Sell | −0.8% | Downgrade | 09.10.26on TipRanks 11:07 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $7.00 → $6.50−7.1% | Hold | +7.4% | Reiterated | 09.10.26on TipRanks 11:07 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $7.00 → $6.50−7.1% | Hold | +7.4% | Reiterated | 09.10.26on TipRanks 11:07 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $8.00 → $6.50−18.8% | Hold | +7.4% | Reiterated | 08.10.26on TipRanks 05:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $7.50 → $6.50−13.3% | Sell | +7.4% | Downgrade | 08.10.26on TipRanks 05:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $8.00 → $6.50−18.8% | Hold | +7.4% | Reiterated | 08.10.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $8.00 → $6.50−18.8% | Hold | +7.4% | Reiterated | 08.10.26on TipRanks 05:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $8.00 → $7.00−12.5% | Hold | +15.7% | Reiterated | 08.10.26on TipRanks 05:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $8.00 → $7.00−12.5% | Hold | +15.7% | Reiterated | 08.10.26on TipRanks 05:05 | — | |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $10.00 | Hold | +65.3% | Initiated | 07.10.26on TipRanks 03:55 | −3.0%next day −2.4% · 5 days −7.2% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $8.00 | Hold | +32.2% | Reiterated | 23.09.26on TipRanks 14:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $8.00 → $7.50−6.2% | Sell | +24.0% | Downgrade | 23.09.26on TipRanks 14:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $8.00 | Hold | +32.2% | Reiterated | 23.09.26on TipRanks 14:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $8.00 | Hold | +32.2% | Reiterated | 23.09.26on TipRanks 14:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $8.50 → $8.00−5.9% | Hold | +32.2% | Reiterated | 23.09.26on TipRanks 14:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $8.00 | Hold | +32.2% | Reiterated | 23.09.26on TipRanks 14:05 | — | |
| Unknown Analyst | Cantor Fitzgerald | $15.00 | Buy | +147.9% | Reiterated | 14.08.26on TipRanks Aug 19 15:17 | +5.5%next day +0.7% · 5 days −3.1% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $16.00 | Buy | +164.5% | Reiterated | 13.08.26on TipRanks 07:00 | 0.0%next day +5.5% · 5 days +5.5% | ↗ |
| Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% | TD Cowen | $15.00 | Buy | +147.9% | Reiterated | 29.06.26on TipRanks Jun 26 06:50 | −1.2%next day −0.7% · 5 days +6.0% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $17.00 → $18.00+5.9% | Buy | +197.5% | Reiterated | 15.05.26on TipRanks 04:55 | +1.1%next day +4.6% · 5 days +32.0% | ↗ |
| Frank Takkinen★★★★★★★★★★#11823 · hits 38% · avg −3.6% | Lake Street | $20.00 → $15.00−25.0% | Buy | +147.9% | Reiterated | 23.01.26on TipRanks 08:50 | −1.7%next day −3.1% · 5 days −8.0% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Anteris Technologies Global Corp.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $15.50 at a price of $7.77 (+99.5%); now: $13.67 at $6.05 (+125.9%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 5 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 18.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.31 (from $-0.33 to $-0.29). Last quarter: $-0.30.
Sales
Next quarter’s sales estimate — $3M (from $0M to $5M). Last quarter: $1M.
Best top-analyst consensus in the sector · General
About Anteris Technologies Global Corp.
- CEO: Wayne Geoffrey Paterson
- Employees: 174
- 860 Blue Gentian Road, Suite 340, Eagan, MN, 55121, US
- anteristech.com
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Data from the stock’s TipRanks forecast page, read 19 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗